Altered responsivity to central administrations of corticotropin-releasing factor in rats with a history of opiate exposures

Behavioral Neuroscience

Volumn 120, Issue 5, 2006, Pages 1169-1174

  Blatchford, Kate E ^a   Choi, Eun A ^a   McNally, Gavan P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Anxiety; Behavior responses; Locomotor activity; Morphine; Opiate exposures; Peptide corticotropin releasing factor; Sensitization

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; MORPHINE; OPIATE; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG DEPENDENCE; DRUG EXPOSURE; GROOMING; LOCOMOTION; MALE; MICROINJECTION; NONHUMAN; RAT; RAT STRAIN; SENSITIZATION; SOCIAL INTERACTION; STRESS;

ANIMALS; AROUSAL; BRAIN; CORTICOTROPIN-RELEASING HORMONE; GROOMING; INJECTIONS, INTRAVENTRICULAR; MALE; MICROINJECTIONS; MORPHINE DEPENDENCE; MOTOR ACTIVITY; NERVE NET; RATS; RATS, WISTAR;

EID: 33750054120     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.120.5.1169     Document Type: Article

References (36)

1. Ambrosio, E., Sharpe, L., & Pilotte, N. (1997). Regional binding to corticotropin releasing factor receptors in brain of rats exposed to chronic cocaine and cocaine withdrawal. Synapse, 25, 272-276.
2. Blatchford, K. E., Diamond, K., Westbrook, R. F., & McNally, G. P. (2005). Increased vulnerability to stress following opiate dependence: Behavioral and autonomic correlates. Behavioral Neuroscience, 119, 1034-1041.
3. Deroche, V., Piazza, P. V., Casolini, P., Maccari, S., Le Moal, M., & Simon, H. (1992). Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion. Brain Research, 598, 343-348.
4. DeSouza, E. B., & Grigoriadis, D. E. (1995). Corticotropin-releasing factor: Physiology, pharmacology, and the role in central nervous system and immune disorders. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The fourth generation of progress (pp. 505-517). New York: Raven.
5. Dunn, A. J., & Berridge, C. W. (1990). Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Research: Brain Research Reviews, 15, 71-100.
6. Dunn, A. J., & File, S. E. (1987). Corticotropin-releasing factor has an anxiogenic action in the social interaction test. Hormones and Behavior, 21, 193-202.
7. Erb, S., Funk, D., Borkowski, S., Watson, S. J., & Akil, H. (2004). Effects of chronic cocaine exposure on corticotropin-releasing factor binding protein in the central nucleus of the amygdala and bed nucleus of the stria terminalis. Neuroscience, 123, 1003-1009.
8. Erb, S., Funk, D., & Le, A. D. (2003). Prior, repeated exposure to cocaine potentiates locomotor responsivity to central injections of corticotropin-releasing factor (CRF) in rats. Psychopharmacology, 170, 383-389.
9. Erb, S., Funk, D., & Le, A. D. (2005). Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: An effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity. Neuroscience Letters, 383, 209-214.
10. Erb, S., Shaham, Y., & Stewart, J. (1998). The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. Journal of Neuroscience, 18, 5529-5536.
11. File, S. E., & Seth, P. (2003). A review of 25 years of the social interaction test. European Journal of Pharmacology, 463, 35-53.
12. Goeders, N. E., & Guerin, G. F. (1994). Non-contingent electric footshock facilitates the acquisition of intravenous cocaine self-administration in rats. Psychopharmacology, 114, 63-70.
13. Heinrichs, S. C., Menzaghi, F., Pich, E. M., Baldwin, H. A., Rassnick, S., Britton, K. T., & Koob, G. F. (1994). Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity. Neuropsychopharmacology, 11, 179-186.
14. Houshyar, H., Cooper, Z. D., & Woods, J. H. (2001). Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: A chronic stress paradigm. Journal of Neuroendocrinology, 13, 862-874.
15. Houshyar, H., Gomez, F., Manalo, S., Bhargava, A., & Dallman, M. F. (2003). Intermittent morphine administration induces dependence and is a chronic stressor in rats. Neuropsychopharmacology, 28, 1960-1972.
16. Houshyar, H., Manalo, S., & Dallman, M. F. (2004). Time-dependent alterations in mRNA expression of brain neuropeptides regulating energy balance and hypothalamo-pituitary-adrenal activity after withdrawal from intermittent morphine treatment. Journal of Neuroscience, 24, 9414-9424.
17. Koob, G. F. (1999). Corticotropin-releasing factor, norepinephrine, and stress. Biological Psychiatry, 46, 1167-1180.
18. Koob, G. F., & Heinrichs, S. C. (1999). A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Research, 848, 141-152.
19. Kreek, M. J., & Koob, G. F. (1998). Drug dependence: Stress and dysregulation of brain reward pathways. Drug and Alcohol Dependence, 51, 23-47.
20. Lack, A. K., Floyd, D. W., & McCool, B. A. (2005). Chronic ethanol ingestion modulates proanxiety factors expressed in rat central amygdala. Alcohol, 36, 83-90.
21. Laorden, M. L., Milanes, M. V., Angel, E., Tankosic, P., & Burlet, A. (2003). Quantitative analysis of corticotropin-releasing factor and arginine vasopressin mRNA in the hypothalamus during chronic morphine treatment in rats: An in situ hybridization study. Journal of Neuroendocrinology, 15, 586-591.
22. Li, Z., Kang, S. S., Lee, S., & Rivier, C. (2005). Effect of ethanol on the regulation of corticotropin-releasing factor (CRF) gene expression. Molecular and Cellular Neurosciences, 29, 345-354.
23. Maj, M., Turchan, J., Smialowska, M., & Przewlocka, B. (2003). Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala. Neuropeptides, 37, 105-110.
24. McNally, G. P., & Akil, H. (2002). Role of corticotropin-releasing factor in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal. Neuroscience, 112, 605-617.
25. McNally, G. P., & Lam, S. (2005). Altered vulnerability to acute opiate withdrawal following stress: Roles of N-methyl-D-aspartate and glucocorticoid receptors. Behavioral Neuroscience, 119, 1215-1221.
26. McNally, G. P., Lee, B., Chiem, J. Y., & Choi, E. A. (2005). The midbrain periaqueductal gray and fear extinction. Opioid receptor subtype and roles of cAMP, protein kinase A, and mitogen-activated protein kinase. Behavioral Neuroscience, 119, 1023-1033.
27. Menzaghi, F., Howard, R. L., Heinrichs, S. C., Vale, W., Rivier, J., & Koob, G. F. (1994). Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. Journal of Pharmacology and Experimental Therapeutics, 269, 564-572.
28. Mills, K. L., Lynskey, M., Teesson, M., Ross, J., & Darke, S. (2005). Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): Prevalence and correlates. Drug and Alcohol Dependence, 77, 243-249.
29. Richter, R. M., Pich, E. M., Koob, G. F., & Weiss, F. (1995). Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by microdialysis. Neuroscience Letters, 187, 169-172.
30. Shaham, Y., Erb, S., Leung, S., Buczek, Y., & Stewart, J. (1998). CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor 1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology, 137, 184-190.
31. Shaham, Y., & Stewart, J. (1995). Stress reinstates heroin-seeking in drug-free animals: An effect mimicking heroin, not withdrawal. Psychopharmacology, 119, 334-341.
32. Shiffman, S., Hickcox, M., Paty, J. A., Gnys, M., Kassel, J. D., & Richards. T. J. (1996). Progression from smoking lapse to relapse: Predictions from abstinence violation effects, nicotine dependence, and lapse characteristics. Journal of Consulting and Clinical Psychology, 64, 993-1002.
33. Slawecki, C. J., Somes, C., & Ehlers, C. L. (1999). Effects of chronic ethanol exposure on neurophysiological responses to corticotropin- releasing factor and neuropeptide Y. Alcohol and Alcoholism, 34, 289-299.
34. Stenzel-Poore, M. P., Heinrichs, S. C., Rivest, S., Koob, G. F., & Vale, W. W. (1994). Overproduction of corticotropin-releasing factor in transgenic mice: A genetic model of anxiogenic behavior. Journal of Neuroscience, 14, 12579-12584.
35. Xu, G. P., Van Bockstaele, E., Reyes, B., Bethea, B., & Valentino, R. J. (2004). Chronic morphine sensitizes the brain norepinephrine system to corticotropin-releasing factor and stress. Journal of Neuroscience, 24, 8193-8197.
36. Zhou, Y., Spangler, R., LaForge, K., Maggos, C., Ho, A., & Kreek, M. J. (1996). Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal. Journal of Pharmacology and Experimental Therapeutics, 279, 351-358.